Factor 5A1 Gene-Silencing siRNA (Sevion Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFactor 5A1 Gene-Silencing siRNA (Sevion Therapeutics)
Drug Alias NameFactor 5A1 Gene-Silencing siRNA (Senesco)eIF-5A1 gene-silencing siRNA (Senesco)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionEukaryotic translation initiation factor 5A inhibitors
TargetsEukaryotic translation initiation factor 5A
Therapy Area/IndicationsInflammationHIV InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEloxx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEloxx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationHIV InfectionsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A